Public Health

GLP 1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world.

New global syndicated survey highlights a striking contradiction at the heart of how obesity is understood, especially by those living with it.

New 14-country study from Ipsos reveals self-blame, outdated narratives and a hidden daily toll.

Ipsos' Market Essentials infographics offer insights on how consumers think, feel, and engage in activities such as shopping, travel, entertainment, socialization, technology and AI, and work in our dynamic, ever-changing world.

Ipsos' Market Essentials infographics offer insights on how consumers think, feel, and engage in activities such as shopping, travel, entertainment, socialization, technology and AI, and work in our dynamic, ever-changing world.

Turn longevity from trend to strategy: where should pharma play - and how to win?

Ipsos' Market Essentials infographics offer insights on how consumers think, feel, and engage in activities such as shopping, travel, entertainment, socialization, technology and AI, and work in our dynamic, ever-changing world.

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.